This study advances PCOS therapeutics by elucidating a novel mechanistic axis linking AGEs-RAGE signaling to NOX4-driven oxidative stress and NF-κB-mediated inflammation, through which BSTJF exerts its therapeutic effects. The gene discussed is NFKB1; the disease is polycystic ovary syndrome.